Recent News

By Category: Countermeasures

U.S. Funds Anthrax Vaccine Trial

(Global Security Newswire) Maryland-based biopharmaceutical company Emergent BioSolutions said on Monday it would receive as much as $8.43 million from the U.S. Health and Human Services Department for an anthrax vaccine trial. The study is part of the company's effort to receive federal authorization for using BioThrax to help treat people exposed to the potential Read More »

June 13, 2012
| Filed under North America, Countermeasures, Policy & Initiatives, and Research
Share

Vaccination schemes on anvil to avert various animal diseases

(Deccan Herald) With the arrival of monsoon the veterinarians in the district too are pulling up their socks to combat various diseases that affect the animals. Going by the adage ‘prevention is better than cure’, this rainy season, the Animal Husbandry and Veterinary Services department in the district has decided to take some precautions to Read More »

June 12, 2012
| Filed under South Asia, Agriculture, Countermeasures, and Public Health
Share

Brown University Develops SMART Biochip

(Global Biodefense) Biomedical engineers at Brown University and Memorial Hospital in Rhode Island have developed a biochip that can detect the presence of influenza by zeroing in on the specific RNA sequence and then using tiny magnets in a tube to separate the flu-ridden sequence from the rest of the RNA strand. The Brown assay Read More »

June 12, 2012
| Filed under North America and Countermeasures
Share

Now open: Broad Agency Announcements

(MedicalCountermeasures.gov) Now open: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza and Chemical, Biological, Radiological and Nuclear Threats. BARDA is soliciting proposals for the advanced research and development of medical countermeasures (MCM) such as vaccines, therapeutics, diagnostics and devices. Specifics of the solicitation can be found under three Broad Read More »

June 12, 2012
| Filed under North America, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

FMD vaccine earns conditional approval

(CattleNetwork.com) The US Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) issued a conditional license for GenVec, Inc.’s foot-and-mouth disease vaccine for use in cattle, the company announced June 7. GenVec also announced that Merial, the animal health division of Sanofi, has the rights to develop and commercialize GenVec’s FMD vaccine for use Read More »